Cell death, clearance and immunity in the skeletal muscle

Cell Death and Differentiation

Volumn 23, Issue 6, 2016, Pages 927-937

  Sciorati, C ^a   Rigamonti, E ^a   Manfredi, A A ^a,b   Rovere Querini, P ^a,b  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN;

ANTIBODY PRODUCTION; APOPTOSIS; AUTOIMMUNITY; AUTOPHAGY; CELL ACTIVATION; CELL DEATH; CELL FUNCTION; CLEARANCE; ECTOPIC TISSUE; HOMEOSTASIS; IMMUNITY; INFLAMMATION; LEUKOCYTE; LIPID STORAGE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MACROPHAGE ACTIVATION; MICROENVIRONMENT; MITOCHONDRIAL MYOPATHY; MUSCLE INJURY; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; MYOBLAST; MYOSITIS; NECROSIS; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; STEM CELL; ANIMAL; HUMAN; IMMUNOLOGY; INJURIES; METABOLISM; PHYSIOLOGY; REGENERATION; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; AUTOANTIGENS; AUTOIMMUNITY; HUMANS; INFLAMMATION; MACROPHAGES; MUSCLE, SKELETAL; REGENERATION; T-LYMPHOCYTES;

EID: 84957895128     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2015.171     Document Type: Review

References (153)

1. Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 2003; 3: 879-889
2. Niederkorn JY. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol 2006; 7: 354-359
3. Matzingerand P, Kamala T. Tissue-based class control: the other side of tolerance. Nat Rev Immunol 2011; 11: 221-230
4. Niederkornand JY, Stein-Streilein J. History and physiology of immune privilege. Ocul Immunol Inflamm 2010; 18: 19-23
5. Perezand VL, Caspi RR. Immune mechanisms in inflammatory and degenerative eye disease. Trends Immunol 2015; 36: 354-363
6. Gadani SP, Walsh JT, Lukens JR, Kipnis J. Dealing with danger in the CNS: the response of the immune system to injury. Neuron 2015; 87: 47-62
7. Burzyn D, Kuswanto W, Kolodin D, Shadrach JL, Cerletti M, Jang Y., et al. A special population of regulatory T cells potentiates muscle repair. Cell 2013; 155: 1282-1295
8. Castiglioni A, Corna G, Rigamonti E, Basso V, Vezzoli M, Monno A., et al. FOXP3+ T cells recruited to sites of sterile skeletal muscle injury regulate the fate of satellite cells and guide effective tissue regeneration. PLoS One 2015; 10: e0128094
9. Smith HK, Maxwell L, Martyn JA, Bass JJ. Nuclear DNA fragmentation and morphological alterations in adult rabbit skeletal muscle after short-term immobilization. Cell Tissue Res 2000; 302: 235-241
10. Siu PM, Pistilli EE, Butler DC, Alway SE. Aging influences cellular and molecular responses of apoptosis to skeletal muscle unloading. Am J Physiol Cell Physiol 2005; 288: C338-C349
11. Dupont-Versteegden EE, Strotman BA, Gurley CM, Gaddy D, Knox M, Fluckey JD., et al. Nuclear translocation of EndoG at the initiation of disuse muscle atrophy and apoptosis is specific to myonuclei. Am J Physiol Regul Integr Comp Physiol 2006; 291: R1730-R1740
12. Andrianjafiniony T, Dupre-Aucouturier S, Letexier D, Couchoux H, Desplanches D. Oxidative stress, apoptosis, and proteolysis in skeletal muscle repair after unloading. Am J Physiol Cell Physiol 2010; 299: C307-C315
13. Allen DL, Roy RR, Edgerton VR. Myonuclear domains in muscle adaptation and disease. Muscle Nerve 1999; 22: 1350-1360
14. Marzetti E, Calvani R, Cesari M, Buford TW, Lorenzi M, Behnke BJ., et al. Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials. Int J Biochem Cell Biol 2013; 45: 2288-2301
15. Tewsand DS, Goebel HH. DNA fragmentation and BCL-2 expression in infantile spinal muscular atrophy. Neuromuscul Disord 1996; 6: 265-273
16. Bruusgaard JC, Egner IM, Larsen TK, Dupre-Aucouturier S, Desplanches D, Gundersen K. No change in myonuclear number during muscle unloading and reloading. J Appl Physiol (1985)2012; 113: 290-296
17. Singhaland N, Martin PT. A role for Galgt1 in skeletal muscle regeneration. Skelet Muscle 2015; 5: 3
18. Bonaldoand P, Sandri M. Cellular and molecular mechanisms of muscle atrophy. Dis Model Mech 2013; 6: 25-39
19. Neely KA, Planetta PJ, Prodoehl J, Corcos DM, Comella CL, Goetz CG., et al. Force control deficits in individuals with Parkinson's disease, multiple systems atrophy, and progressive supranuclear palsy. PLoS One 2013; 8: e58403
20. Wohlgemuth SE, Seo AY, Marzetti E, Lees HA, Leeuwenburgh C. Skeletal muscle autophagy and apoptosis during aging: effects of calorie restriction and life-long exercise. Exp Gerontol 2010; 45: 138-148
21. Marzetti E, Lawler JM, Hiona A, Manini T, Seo AY, Leeuwenburgh C. Modulation of ageinduced apoptotic signaling and cellular remodeling by exercise and calorie restriction in skeletal muscle. Free Radic Biol Med 2008; 44: 160-168
22. Pollack M, Phaneuf S, Dirks A, Leeuwenburgh C. The role of apoptosis in the normal aging brain, skeletal muscle, and heart. Ann NY Acad Sci 2002; 959: 93-107
23. Dirksand A, Leeuwenburgh C. Apoptosis in skeletal muscle with aging. Am J Physiol Regul Integr Comp Physiol 2002; 282: R519-R527
24. Martinez-Lopez N, Athonvarangkul D, Singh R. Autophagy and aging. Adv Exp Med Biol. 2015; 847: 73-87
25. Vezzoli M, Castellani P, Corna G, Castiglioni A, Bosurgi L, Monno A., et al. High-mobility group box 1 release and redox regulation accompany regeneration and remodeling of skeletal muscle. Antioxid Redox Signal 2011; 15: 2161-2174
26. Lopes-Ferreira M, Nunez J, Rucavado A, Farsky SH, Lomonte B, Angulo Y., et al. Skeletal muscle necrosis and regeneration after injection of Thalassophryne nattereri (niquim) fish venom in mice. Int J Exp Pathol 2001; 82: 55-64
27. Podhorska-Okolow M, Sandri M, Zampieri S, Brun B, Rossini K, Carraro U. Apoptosis of myofibres and satellite cells: exercise-induced damage in skeletal muscle of the mouse. Neuropathol Appl Neurobiol 1998; 24: 518-531
28. Arslan S, Erdem S, Sivri A, Hascelik Z, Tan E. Exercise-induced apoptosis of rat skeletal muscle and the effect of meloxicam. Rheumatol Int 2002; 21: 133-136
29. Haralambieand G, Senser L. Metabolic changes in man during long-distance swimming. Eur J Appl Physiol Occup Physiol 1980; 43: 115-125
30. Proskeand U, Allen TJ. Damage to skeletal muscle from eccentric exercise. Exerc Sport Sci Rev 2005;. 33: 98-104
31. Behringer M, Montag J, Franz A, McCourt ML, Mester J, Nosaka KK. Exhaustive exercise- A near death experience for skeletal muscle cells?. Med Hypotheses 2014; 83: 758-765
32. Vezzoli M, Castellani P, Campana L, Corna G, Bosurgi L, Manfredi AA., et al. Redox remodeling: a candidate regulator of HMGB1 function in injured skeletal muscle. Ann NY Acad Sci 2010; 1209: 83-90
33. Bianchiand ME, Manfredi AA. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev 2007; 220: 35-46
34. Venereau E, Casalgrandi M, Schiraldi M, Antoine DJ, Cattaneo A, De Marchis F., et al. Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med 2012; 209: 1519-1528
35. Venereau E, Schiraldi M, Uguccioni M, Bianchi ME. HMGB1 and leukocyte migration during trauma and sterile inflammation. Mol Immunol 2013; 55: 76-82
36. Janko C, Filipovic M, Munoz LE, Schorn C, Schett G, Ivanovic-Burmazovic I., et al. Redox modulation of HMGB1-related signaling. Antioxid Redox Signal 2014; 20: 1075-1085
37. Maugeri N, Rovere-Querini P, Baldini M, Baldissera E, Sabbadini MG, Bianchi ME., et al. Oxidative stress elicits platelet/leukocyte inflammatory interactions via HMGB1: a candidate for microvessel injury in sytemic sclerosis. Antioxid Redox Signal 2014; 20: 1060-1074
38. Campana L, Bosurgi L, Bianchi ME, Manfredi AA, Rovere-Querini P. Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells. J Leukoc Biol 2009; 86: 609-615
39. Campana L, Santarella F, Esposito A, Maugeri N, Rigamonti E, Monno A., et al. Leukocyte HMGB1 is required for vessel remodeling in regenerating muscles. J Immunol 2014; 192: 5257-5264
40. Zong M, Bruton JD, Grundtman C, Yang H, Li JH, Alexanderson H., et al. TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis. Ann Rheum Dis 2013; 72: 1390-1399
41. Grundtman C, Bruton J, Yamada T, Ostberg T, Pisetsky DS, Harris HE., et al. Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies. FASEB J 2010; 24: 570-578
42. Tews DS. Apoptosis and muscle fibre loss in neuromuscular disorders. Neuromuscul Disord 2002; 12: 613-622
43. Tews DS. Muscle-fiber apoptosis in neuromuscular diseases. Muscle Nerve 2005; 32: 443-458
44. Matsumuraand K, Campbell KP. Deficiency of dystrophin-Associated proteins: a common mechanism leading to muscle cell necrosis in severe childhood muscular dystrophies. Neuromuscul Disord 1993; 3: 109-118
45. Tewsand DS, Goebel HH. DNA-fragmentation and expression of apoptosis-related proteins in muscular dystrophies. Neuropathol Appl Neurobiol 1997; 23: 331-338
46. Sugiura T, Murakawa Y, Nagai A, Kondo M, Kobayashi S. Fas and Fas ligand interaction induces apoptosis in inflammatory myopathies: CD4+ T cells cause muscle cell injury directly in polymyositis. Arthritis Rheum 1999; 42: 291-298
47. Zhao Y, Fedczyna TO, McVicker V, Caliendo J, Li H, Pachman LM. Apoptosis in the skeletal muscle of untreated children with juvenile dermatomyositis: impact of duration of untreated disease. Clin Immunol 2007; 125: 165-172
48. Maugeri N, Campana L, Gavina M, Covino C, De Metrio M, Panciroli C., et al. Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps. J Thromb Haemost 2014; 12: 2074-2088
49. Manfredi AA, Covino C, Rovere-Querini P, Maugeri N. Instructive influences of phagocytic clearance of dying cells on neutrophil extracellular trap generation. Clin Exp Immunol 2015; 179: 24-29
50. Oklu R, Albadawi H, Jones JE, Yoo HJ, Watkins MT. Reduced hind limb ischemiareperfusion injury in Toll-like receptor-4 mutant mice is associated with decreased neutrophil extracellular traps. J Vasc Surg 2013; 58: 1627-1636
51. Dentice M, Ambrosio R, Damiano V, Sibilio A, Luongo C, Guardiola O., et al. Intracellular inactivation of thyroid hormone is a survival mechanism for muscle stem cell proliferation and lineage progression. Cell Metab 2014; 20: 1038-1048
52. Abou-Khalil R, Le Grand F, Pallafacchina G, Valable S, Authier FJ, Rudnicki M.A., et al. Autocrine and paracrine angiopoietin 1/Tie-2 signaling promotes muscle satellite cell selfrenewal. Cell Stem Cell 2009; 5: 298-309
53. Francois S, D'Orlando C, Fatone T, Touvier T, Pessina P, Meneveri R., et al. Necdin enhances myoblasts survival by facilitating the degradation of the mediator of apoptosis CCAR1/CARP1. PLoS One 2012; 7: e43335
54. Joe AW, Yi L, Natarajan A, Le Grand F, So L, Wang J., et al. Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat Cell Biol 2010; 12: 153-163
55. Uezumi A, Fukada S, Yamamoto N, Takeda S, Tsuchida K. Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat Cell Biol 2010; 12: 143-152
56. Lemos DR, Babaeijandaghi F, Low M, Chang CK, Lee ST, Fiore D., et al. Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro/ adipogenic progenitors. Nat Med 2015; 21: 786-794
57. Serhanand CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 2005; 6: 1191-1197
58. Mauro A. Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 1961; 9: 493-495
59. Zammit PS, Relaix F, Nagata Y, Ruiz AP, Collins CA, Partridge TA., et al. Pax7 and myogenic progression in skeletal muscle satellite cells. J Cell Sci 2006; 119: 1824-1832
60. Dhawanand J, Rando TA. Stem cells in postnatal myogenesis: molecular mechanisms of satellite cell quiescence, activation and replenishment. Trends Cell Biol 2005; 15: 666-673
61. McKinnell IW, Parise G, Rudnicki M.A. Muscle stem cells and regenerative myogenesis. Curr Top Dev Biol 2005; 71: 113-130
62. Relaixand F, Zammit PS. Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage. Development 2012; 139: 2845-2856
63. Buckingham M. Skeletal muscle formation in vertebrates. Curr Opin Genet Dev 2001; 11: 440-448
64. Brigitte M, Schilte C, Plonquet A, Baba-Amer Y, Henri A, Charlier C., et al. Muscle resident macrophages control the immune cell reaction in a mouse model of notexin-induced myoinjury. Arthritis Rheum 2010; 62: 268-279
65. Yokota M, Suzuki K, Tokoyoda K, Meguro K, Hosokawa J, Tanaka S., et al. Roles of mast cells in the pathogenesis of inflammatory myopathy. Arthritis Res Ther 2014; 16: R72
66. Tidball JG, Dorshkind K, Wehling-Henricks M. Shared signaling systems in myeloid cell-mediated muscle regeneration. Development 2014; 141: 1184-1196
67. Tidball JG, Berchenko E, Frenette J. Macrophage invasion does not contribute to muscle membrane injury during inflammation. J Leukoc Biol 1999; 65: 492-498
68. Chazaud B. Macrophages: supportive cells for tissue repair and regeneration. Immunobiology 2014; 219: 172-178
69. Bosurgi L, Corna G, Vezzoli M, Touvier T, Cossu G, Manfredi AA., et al. Transplanted mesoangioblasts require macrophage IL-10 for survival in a mouse model of muscle injury. J Immunol. 2012; 188: 6267-6277
70. Bosurgi L, Manfredi AA, Rovere-Querini P. Macrophages in injured skeletal muscle: a perpetuum mobile causing and limiting fibrosis, prompting or restricting resolution and regeneration. Front Immunol 2011; 2: 62
71. Tidballand JG, Villalta SA. Regulatory interactions between muscle and the immune system during muscle regeneration. Am J Physiol Regul Integr Comp Physiol 2010; 298: R1173-R1187
72. Villalta SA, Rosenthal W, Martinez L, Kaur A, Sparwasser T, Tidball JG., et al. Regulatory T cells suppress muscle inflammation and injury in muscular dystrophy. Sci Transl Med 2014; 6: 258ra142
73. Venalisand P, Lundberg IE. Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy. Rheumatology Oxford) 2014; 53: 397-405
74. Tidballand JG, Wehling-Henricks M. Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivo. J Physiol 2007; 578: 327-336
75. Arnold L, Henry A, Poron F, Baba-Amer Y, Van Rooijen N, Plonquet A., et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 2007; 204: 1057-1069
76. Ruffell D, Mourkioti F, Gambardella A, Kirstetter P, Lopez RG, Rosenthal N., et al. A CREBC/ EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proc Natl Acad Sci USA 2009; 106: 17475-17480
77. Lawrenceand T, Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 2011; 11: 750-761
78. Mosserand DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958-969
79. Perdiguero E, Sousa-Victor P, Ruiz-Bonilla V, Jardi M, Caelles C, Serrano AL., et al. p38/ MKP-1-regulated AKT coordinates macrophage transitions and resolution of inflammation during tissue repair. J Cell Biol 2011; 195: 307-322
80. Perdiguero E, Kharraz Y, Serrano AL, Munoz-Canoves P. MKP-1 coordinates ordered macrophage-phenotype transitions essential for stem cell-dependent tissue repair. Cell Cycle 2012; 11: 877-886
81. Mounier R, Theret M, Arnold L, Cuvellier S, Bultot L, Goransson O., et al. AMPKalpha1 regulates macrophage skewing at the time of resolution of inflammation during skeletal muscle regeneration. Cell Metab 2013; 18: 251-264
82. Gondin J, Theret M, Duhamel G, Pegan K, Mathieu JR, Peyssonnaux C., et al. Myeloid HIFs are dispensable for resolution of inflammation during skeletal muscle regeneration. J Immunol 2015; 194: 3389-3399
83. Heredia JE, Mukundan L, Chen FM, Mueller AA, Deo RC, Locksley RM., et al. Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell 2013; 153: 376-388
84. Hochreiter-Hufford AE, Lee CS, Kinchen JM, Sokolowski JD, Arandjelovic S, Call JA., et al. Phosphatidylserine receptor BAI1 and apoptotic cells as new promoters of myoblast fusion. Nature 2013; 497: 263-267
85. Arandjelovicand S, Ravichandran KS. Phagocytosis of apoptotic cells in homeostasis. Nat Immunol 2015; 16: 907-917
86. Poon IK, Lucas CD, Rossi AG, Ravichandran KS. Apoptotic cell clearance: basic biology and therapeutic potential. Nat Rev Immunol 2014; 14: 166-180
87. Kimani SG, Geng K, Kasikara C, Kumar S, Sriram G, Wu Y., et al. Contribution of defective PS recognition and efferocytosis to chronic inflammation and autoimmunity. Front Immunol 2014; 5: 566
88. Wickman G, Julian L, Olson MF. How apoptotic cells aid in the removal of their own cold dead bodies. Cell Death Differ 2012; 19: 735-742
89. Segawaand K, Nagata S. An apoptotic 'eat me' signal: phosphatidylserine exposure. Trends Cell Biol 2015; 25: 639-650
90. Dee K, Freer M, Mei Y, Weyman CM. Apoptosis coincident with the differentiation of skeletal myoblasts is delayed by caspase 3 inhibition and abrogated by MEK-independent constitutive Ras signaling. Cell Death Differ. 2002; 9: 209-218
91. Van den Eijnde SM, Van den Hoff MJ, Reutelingsperger CP, Van Heerde WL, Henfling ME, Vermeij-Keers C., et al. Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation. J Cell Sci 2001; 114: 3631-3642
92. Jeongand J, Conboy IM. Phosphatidylserine directly and positively regulates fusion of myoblasts into myotubes. Biochem Biophys Res Commun 2011; 414: 9-13
93. Sampaolesi M, Torrente Y, Innocenzi A, Tonlorenzi R, D'Antona G, Pellegrino M.A., et al. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-Arterial delivery of mesoangioblasts. Science 2003; 301: 487-492
94. Lolmede K, Campana L, Vezzoli M, Bosurgi L, Tonlorenzi R, Clementi E., et al. Inflammatory and alternatively activated human macrophages attract vessel-Associated stem cells, relying on separate HMGB1- And MMP-9-dependent pathways. J Leukoc Biol 2009; 85: 779-787
95. Bosurgi L, Brunelli S, Rigamonti E, Monno A, Manfredi AA, Rovere-Querini P. Vesselassociated myogenic precursors control macrophage activation and clearance of apoptotic cells. Clin Exp Immunol 2015; 179: 62-67
96. Triplett WT, Baligand C, Forbes SC, Willcocks RJ, Lott DJ, DeVos S., et al. Chemical shift-based MRI to measure fat fractions in dystrophic skeletal muscle. Magn Reson Med 2013; 72: 8-19
97. Reimersand CD, Finkenstaedt M. Muscle imaging in inflammatory myopathies. Curr Opin Rheumatol 1997; 9: 475-485
98. Barany M, Venkatasubramanian PN, Mok E, Siegel IM, Abraham E, Wycliffe ND., et al. Quantitative and qualitative fat analysis in human leg muscle of neuromuscular diseases by 1H MR spectroscopy in vivo. Magn Reson Med 1989; 10: 210-226
99. Sciorati C, Clementi E, Manfredi AA, Rovere-Querini P. Fat deposition and accumulation in the damaged and inflamed skeletal muscle: cellular and molecular players. Cell Mol Life Sci 2015; 72: 2135-2156
100. Mozzetta C, Consalvi S, Saccone V, Tierney M, Diamantini A, Mitchell KJ., et al. Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice. EMBO Mol Med 2013; 5: 626-639
101. Hinz B. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 2007; 127: 526-537
102. Summan M, Warren GL, Mercer RR, Chapman R, Hulderman T, Van Rooijen N., et al. Macrophages and skeletal muscle regeneration: a clodronate-containing liposome depletion study. Am J Physiol Regul Integr Comp Physiol 2006; 290: R1488-R1495
103. Zordan P, Rigamonti E, Freudenberg K, Conti V, Azzoni E, Rovere-Querini P., et al. Macrophages commit postnatal endothelium-derived progenitors to angiogenesis and restrict endothelial to mesenchymal transition during muscle regeneration. Cell Death Dis 2014; 5: e1031
104. Rigamonti E, Zordan P, Sciorati C, Rovere-Querini P, Brunelli S. Macrophage plasticity in skeletal muscle repair. Biomed Res Int 2014; 2014: 560629
105. Balboni TA, Gobezie R, Mamon HJ. Heterotopic ossification: pathophysiology, clinical features, and the role of radiotherapy for prophylaxis. Int J Radiat Oncol Biol Phys 2006; 65: 1289-1299
106. Genet F, Kulina I, Vaquette C, Torossian F, Millard S, Pettit AR., et al. Neurological heterotopic ossification following spinal cord injury is triggered by macrophage-mediated inflammation in muscle. J Pathol 2015; 236: 229-240
107. Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, Choi IH., et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 2006; 38: 525-527
108. Ramirez DM, Ramirez MR, Reginato AM, Medici D. Molecular and cellular mechanisms of heterotopic ossification. Histol Histopathol 2014; 29: 1281-1285
109. Rayavarapu S, Coley W, Kinder TB, Nagaraju K. Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weakness. Skeletal Muscle 2013; 3: 13
110. Bender A, Ernst N, Iglesias A, Dornmair K, Wekerle H, Hohlfeld R. T cell receptor repertoire in polymyositis: clonal expansion of autoaggressive CD8+ T cells. J Exp Med 1995; 181: 1863-1868
111. Hohlfeldand R, Engel AG. Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies. Ann Neurol 1991; 29: 498-507
112. Stone KB, Oddis CV, Fertig N, Katsumata Y, Lucas M, Vogt M., et al. Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy. Arthritis Rheum 2007; 56: 3125-3131
113. Mammen AL, Casciola-Rosen LA, Hall JC, Christopher-Stine L, Corse AM, Rosen A. Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle. Arthritis Rheum 2009; 60: 3784-3793
114. Casciola-Rosen L, Nagaraju K, Plotz P, Wang K, Levine S, Gabrielson E., et al. Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med 2005; 201: 591-601
115. Suber TL, Casciola-Rosen L, Rosen A. Mechanisms of disease: autoantigens as clues to the pathogenesis of myositis. Nat Clin Pract Rheumatol 2008; 4: 201-209
116. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179: 1317-1330
117. Casciola-Rosen L, Rosen A, Petri M, Schlissel M. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci USA 1996; 93: 1624-1629
118. Bellone M, Iezzi G, Rovere P, Galati G, Ronchetti A, Protti MP., et al. Processing of engulfed apoptotic bodies yields T cell epitopes. J Immunol 1997; 159: 5391-5399
119. Albert ML, Pearce SF, Francisco LM, Sauter B, Roy P, Silverstein RL., et al. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 1998; 188: 1359-1368
120. Pengand Y, Elkon KB. Autoimmunity in MFG-E8-deficient mice is associated with altered trafficking and enhanced cross-presentation of apoptotic cell antigens. J Clin Invest 2011; 121: 2221-2241
121. Bondanza A, Zimmermann VS, Dell'Antonio G, Cin ED, Balestrieri G, Tincani A., et al. Requirement of dying cells and environmental adjuvants for the induction of autoimmunity. Arthritis Rheum 2004; 50: 1549-1560
122. Ronchetti A, Rovere P, Iezzi G, Galati G, Heltai S, Protti MP., et al. Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokines. J Immunol 1999; 163: 130-136
123. Rovere P, Manfredi AA, Vallinoto C, Zimmermann VS, Fascio U, Balestrieri G., et al. Dendritic cells preferentially internalize apoptotic cells opsonized by anti-beta2-glycoprotein I antibodies. J Autoimmun 1998; 11: 403-411
124. Rovere P, Vallinoto C, Bondanza A, Crosti MC, Rescigno M, Ricciardi-Castagnoli P., et al. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J Immunol 1998; 161: 4467-4471
125. Casares N, Pequignot MO, Tesniere A, Ghiringhelli F, Roux S, Chaput N., et al. Caspasedependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med 2005; 202: 1691-1701
126. Green DR, Ferguson T, Zitvogel L, Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev Immunol 2009; 9: 353-363
127. Kepp O, Senovilla L, Vitale I, Vacchelli E, Adjemian S, Agostinis P., et al. Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology 2014; 3: e955691
128. Zong M, Bruton JD, Grundtman C, Yang H, Li JH, Alexanderson H., et al. TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis. Ann Rheum Dis 2013; 72: 1390-1399
129. Cappelletti C, Galbardi B, Kapetis D, Vattemi G, Guglielmi V, Tonin P., et al. Autophagy, inflammation and innate immunity in inflammatory myopathies. PLoS One 2014; 9: e111490
130. Nagaraju K, Casciola-Rosen L, Lundberg I, Rawat R, Cutting S, Thapliyal R., et al. Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum 2005; 52: 1824-1835
131. Rayavarapu S, Coley W, Van Der Meulen JH, Cakir E, Tappeta K, Kinder TB., et al. Activation of the ubiquitin proteasome pathway in a mouse model of inflammatory myopathy: a potential therapeutic target. Arthritis Rheum 2013; 65: 3248-3258
132. Sciorati C, Monno A, Ascherman DP, Seletti E, Manfredi AA, Rovere-Querini P. Required role of apoptotic myogenic precursors and Toll-like receptor stimulation for the establishment of autoimmune myositis in experimental murine models. Arthritis Rheumatol 2015; 67: 809-822
133. Tournadreand A, Miossec P. A critical role for immature muscle precursors in myositis. Nat Rev Rheumatol 2013; 9: 438-442
134. Pereira BP, Tan BL, Han HC, Zou Y, Aung KZ, Leong DT. Intramuscular nerve damage in lacerated skeletal muscles may direct the inflammatory cytokine response during recovery. J Cell Biochem 2012; 113: 2330-2345
135. Kaariainen M, Kaariainen J, Jarvinen TL, Sievanen H, Kalimo H, Jarvinen M. Correlation between biomechanical and structural changes during the regeneration of skeletal muscle after laceration injury. J Orthop Res 1998; 16: 197-206
136. Dobek GL, Fulkerson ND, Nicholas J, Schneider BS. Mouse model of muscle crush injury of the legs. Comp Med 2013; 63: 227-232
137. Ghalyand A, Marsh DR. Aging-Associated oxidative stress modulates the acute inflammatory response in skeletal muscle after contusion injury. Exp Gerontol 2010; 45: 381-388
138. Winkler T, von Roth P, Matziolis G, Schumann MR, Hahn S, Strube P., et al. Time course of skeletal muscle regeneration after severe trauma. Acta Orthop 2011; 82: 102-111
139. Ambrosio F, Ferrari RJ, Distefano G, Plassmeyer JM, Carvell GE, Deasy BM., et al. The synergistic effect of treadmill running on stem-cell transplantation to heal injured skeletal muscle. Tissue Eng Part A 2010; 16: 839-849
140. Stauber WT. Factors involved in strain-induced injury in skeletal muscles and outcomes of prolonged exposures. J Electromyogr Kinesiol 2004; 14: 61-70
141. Banks GB, Combs AC, Chamberlain JR, Chamberlain JS. Molecular and cellular adaptations to chronic myotendinous strain injury in mdx mice expressing a truncated dystrophin. Hum Mol Genet 2008; 17: 3975-3986
142. Pratt SJ, Lawlor MW, Shah SB, Lovering RM. An in vivo rodent model of contractioninduced injury in the quadriceps muscle. Injury 2012; 43: 788-793
143. De Paiva Carvalho RL, Leal-Junior EC, Petrellis MC, Marcos RL, De Carvalho MH, De Nucci G., et al. Effects of low-level laser therapy (LLLT) and diclofenac (topical and intramuscular) as single and combined therapy in experimental model of controlled muscle strain in rats. Photochem Photobiol 2013; 89: 508-512
144. Warren GL, Summan M, Gao X, Chapman R, Hulderman T, Simeonova PP. Mechanisms of skeletal muscle injury and repair revealed by gene expression studies in mouse models. J Physiol 2007; 582: 825-841
145. Szelenyiand ER, Urso ML. Time-course analysis of injured skeletal muscle suggests a critical involvement of ERK1/2 signaling in the acute inflammatory response. Muscle Nerve 2012; 45: 552-561
146. Vignaud A, Hourde C, Medja F, Agbulut O, Butler-Browne G, Ferry A. Impaired skeletal muscle repair after ischemia-reperfusion injury in mice. J Biomed Biotechnol 2010; 2010: 724914
147. Loenneke JP, Thiebaud RS, Abe T. Does blood flow restriction result in skeletal muscle damage?. A critical review of available evidence. Scand J Med Sci Sports 2014; 24: e415-e422
148. Van Der Meer SF, Jaspers RT, Jones DA, Degens H. Time-course of changes in the myonuclear domain during denervation in young-Adult and old rat gastrocnemius muscle. Muscle Nerve 2011; 43: 212-222
149. Hikida RS, Van Nostran S, Murray JD, Staron RS, Gordon SE, Kraemer WJ. Myonuclear loss in atrophied soleus muscle fibers. Anat Rec 1997; 247: 350-354
150. Dupont-Versteegden EE, Murphy RJ, Houle JD, Gurley CM, Peterson CA. Activated satellite cells fail to restore myonuclear number in spinal cord transected and exercised rats. Am J Physiol 1999; 277: C589-C597
151. Harris JB. Myotoxic phospholipases A2 and the regeneration of skeletal muscles. Toxicon 2003; 42: 933-945
152. Kawai H, Nishino H, Kusaka K, Naruo T, Tamaki Y, Iwasa M. Experimental glycerol myopathy: a histological study. Acta Neuropathol 1990; 80: 192-197
153. Pisani DF, Bottema CD, Butori C, Dani C, Dechesne CA. Mouse model of skeletal muscle adiposity: a glycerol treatment approach. Biochem Biophys Res Commun 2010; 396: 767-773